The delivery system developed at Western uses bacteria’s natural ability to replicate – called bacterial conjugation – to deliver CRISPR to specific bacteria, in order to alter its DNA and kill it.
Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria.
Published today in Nature Communications, this study opens up the possibility of using CRISPR to alter the makeup of the human microbiome in a way that could be personalized and specific from person to person. It also presents a potential alternative to traditional antibiotics to kill bacteria like Staphyloccous aureus (Staph A) or Escherichia coli (E. coli).
“One of the major reasons that I am excited about this work is that it has a wide range of possible real-world applications,” said Bogumil Karas, PhD, Assistant Professor at Western’s Schulich School of Medicine & Dentistry. “It has the potential for development of next generation antimicrobial agents that would be effective even for bacteria that are resistant to all known antibiotics. This technology could also be used to help ‘good’ bacteria produce compounds to treat diseases caused by protein deficiencies.”
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats and can be programmed to target specific stretches of genetic code and to edit DNA at precise locations. Researchers use CRISPR to permanently modify genes in living cells and organisms.
In this way, CRISPR can be programmed to kill bacteria, but until now there wasn’t a way to efficiently and specifically target certain bacterial strains.
“Using CRISPR to kill things isn’t a new idea because that’s what CRISPR does naturally,” said David Edgell, PhD, Professor at Schulich Medicine & Dentistry. “The problem has always been how you get CRISPR to where you want it to go. Other delivery systems could only go to a few spots, where ours can go anywhere.”
The delivery system developed at Western uses bacteria’s natural ability to replicate – called bacterial conjugation – to deliver CRISPR to specific bacteria, in order to alter its DNA and kill it.
“Specific delivery of any therapeutic agent, including CRISPR, is usually one of the biggest bottlenecks in development of new treatments. By developing this new delivery system, we created new tools that could help us in the development of more effective therapies in the near future,” said Karas.
The team says their delivery system is not only broadly applicable, but it is also more efficient than previous systems.
“We were able to show near complete transfer of the delivery vehicle to another bacterial species under conditions where they are in intimate contact – in a biofilm. This is important because biofilms are the natural state of the majority of bacteria, and being able to transfer DNA under these conditions is typically difficult, but we found a way to make it easy and efficient,” said Gregory Gloor, PhD, Professor at Schulich Medicine & Dentistry.
Learn more: Researchers unlock potential to use CRISPR to alter the microbiome
The Latest on: Next generation antimicrobial agents
via Google News
The Latest on: Next generation antimicrobial agents
- Gene sequencing bacteria in natural environment sheds new light on antimicrobial resistanceon April 12, 2021 at 8:10 am
A team of researchers from multiple institutions in the U.K. and the U.S. has learned more about the development of antimicrobial resistance by studying hundreds of samples of bacteria in their ...
- Travelport+; a next-generation platform for a new era of travelon April 7, 2021 at 1:03 am
Worldwide leader in travel retail, Travelport, has today launched its next-generation platform, Travelport+. Travelport+ is the centerpiece of Travelport's new global strategy and is designed to ...
- Funding the Next Generation of Cancer Therapieson April 2, 2021 at 7:59 am
Investors are favoring biopharmaceutical firms that plan to launch orchestrated attacks on cancer—attacks that engage multiple immune mechanisms to overcome resistance.
- Global Next Generation Blowing Agents Market 2020 Consumption Volume, Competitive Dynamics, Industry Outlook and Forecast 2025on March 29, 2021 at 10:32 am
Mar 29, 2021 (CDN Newswire via Comtex) -- MarketsandResearch.biz has published a report titled Global Next Generation Blowing Agents Market Growth 2020-2025 that supplies an in-depth overview of ...
- Catheter-Related Infection Prevention Efforts Must Broaden to Protect Patient Safetyon March 29, 2021 at 5:11 am
This next generation of antimicrobial dressings uses chlorhexidine to a fuller extent, making the antimicrobial agent more effective against bacteria and other organisms on the skin for longer ...
- Next-Generation Imaging May Lead to Change in Management of Prostate Cancer, Expert Sayson March 16, 2021 at 7:00 am
The use of next-generation imaging, like PSMA PET, has been shown to be superior compared with conventional imaging and may become a homestay in prostate cancer care in the future. Next-generation ...
- Canadian actor Jahmil French of 'Degrassi: The Next Generation' has died, says agenton March 2, 2021 at 2:29 pm
TORONTO — Canadian actor Jahmil French of "Degrassi: The Next Generation" fame has died. His agent, Gabrielle Kachman, confirmed the news to The Canadian Press through a statement. Kachman did ...
- Antimicrobial Impact on the Skin Microbiomeon August 12, 2020 at 9:47 pm
Advances in high-throughput ("next generation ... Topical antimicrobial treatments can elicit shifts to resident skin bacterial communities and reduce colonization by Staphylococcus aureus competitors ...
via Bing News